Stay updated on Inotuzumab Ozogamicin in ALL Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin in ALL Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin in ALL Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check46 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check60 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check68 days agoChange DetectedThe intervention type has been updated to 'Verified 2021-12' by Gruppo Italiano Malattie EMatologiche dell'Adulto, with the last known status now listed as 'Recruiting' and a revision to version 2.14.0.SummaryDifference3%
- Check97 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Inotuzumab Ozogamicin in ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin in ALL Clinical Trial page.